171 related articles for article (PubMed ID: 31727938)
21. Stem cells in breast tumours: are they ready for the clinic?
Ablett MP; Singh JK; Clarke RB
Eur J Cancer; 2012 Sep; 48(14):2104-16. PubMed ID: 22542086
[TBL] [Abstract][Full Text] [Related]
22. Sec23a inhibits the self-renewal of melanoma cancer stem cells via inactivation of ER-phagy.
Sun Z; Liu D; Zeng B; Zhao Q; Li X; Chen H; Wang J; Rosie Xing H
Cell Commun Signal; 2022 Mar; 20(1):22. PubMed ID: 35236368
[TBL] [Abstract][Full Text] [Related]
23. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
24. β3-Adrenoreceptor Blockade Induces Stem Cells Differentiation in Melanoma Microenvironment.
Calvani M; Bruno G; Dabraio A; Subbiani A; Bianchini F; Fontani F; Casazza G; Vignoli M; De Logu F; Frenos S; Filippi L; Favre C
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093135
[TBL] [Abstract][Full Text] [Related]
25. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
[TBL] [Abstract][Full Text] [Related]
26. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
[TBL] [Abstract][Full Text] [Related]
27. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
[TBL] [Abstract][Full Text] [Related]
28. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
Li D; Zhang T; Gu W; Li P; Cheng X; Tong T; Wang W
Oncol Rep; 2015 May; 33(5):2291-8. PubMed ID: 25760144
[TBL] [Abstract][Full Text] [Related]
29. Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells.
Xia W; Lo CM; Poon RYC; Cheung TT; Chan ACY; Chen L; Yang S; Tsao GSW; Wang XQ
Oncotarget; 2017 Jun; 8(24):38811-38824. PubMed ID: 28415588
[TBL] [Abstract][Full Text] [Related]
30. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
[TBL] [Abstract][Full Text] [Related]
31. Cancer stem cells sustaining the growth of mouse melanoma are not rare.
Zhong Y; Guan K; Zhou C; Ma W; Wang D; Zhang Y; Zhang S
Cancer Lett; 2010 Jun; 292(1):17-23. PubMed ID: 19944522
[TBL] [Abstract][Full Text] [Related]
32. The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells.
Andreucci E; Peppicelli S; Ruzzolini J; Bianchini F; Biagioni A; Papucci L; Magnelli L; Mazzanti B; Stecca B; Calorini L
J Mol Med (Berl); 2020 Oct; 98(10):1431-1446. PubMed ID: 32803272
[TBL] [Abstract][Full Text] [Related]
33. Tumor-initiating properties of breast cancer and melanoma cells in vivo are not invariably reflected by spheroid formation in vitro, but can be increased by long-term culturing as adherent monolayers.
Kuch V; Schreiber C; Thiele W; Umansky V; Sleeman JP
Int J Cancer; 2013 Feb; 132(3):E94-105. PubMed ID: 22907275
[TBL] [Abstract][Full Text] [Related]
34. Bench to Bedside: New Therapeutic Approaches with Extracellular Vesicles and Engineered Biomaterials for Targeting Therapeutic Resistance of Cancer Stem Cells.
Ingavle G; Das M
ACS Biomater Sci Eng; 2022 Nov; 8(11):4673-4696. PubMed ID: 36194142
[TBL] [Abstract][Full Text] [Related]
35. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
[TBL] [Abstract][Full Text] [Related]
36. An alginate-based platform for cancer stem cell research.
Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
[TBL] [Abstract][Full Text] [Related]
37. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W
Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
[TBL] [Abstract][Full Text] [Related]
38. Cancer stem cells in solid tumors.
Ailles LE; Weissman IL
Curr Opin Biotechnol; 2007 Oct; 18(5):460-6. PubMed ID: 18023337
[TBL] [Abstract][Full Text] [Related]
39. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
Huang R; Rofstad EK
Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
[TBL] [Abstract][Full Text] [Related]
40. Cell biological profiling of reprogrammed cancer stem cell-like colon cancer cells maintained in culture.
Hirashima K; Yue F; Kobayashi M; Uchida Y; Nakamura S; Tomotsune D; Matsumoto K; Takizawa-Shirasawa S; Yokoyama T; Kanno H; Sasaki K
Cell Tissue Res; 2019 Mar; 375(3):697-707. PubMed ID: 30284085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
